People in the Spotlight 2

🦠 Day 2 of People in the Spotlight — meet three more colleagues from Prof. Surbhi Malhotra-Kumar’s group as they share what drives their work, from protecting newborns to understanding respiratory infections, and how they each play a part in tackling AMR.

👤 Anouk Vanderstraeten | Every sample is a contribution

Anouk is grateful that effective antibiotics are available when we need them, and wants to help preserve that possibility for others. Working in the lab offers a way to make a personal contribution.

Through ECRAID-PRIME, Anouk helps analyse thousands of nose and throat swabs from patients across Europe, identifying pathogens and assessing whether treatments such as antiviral nasal sprays help clear viruses faster. For Anouk, this work contributes to evidence that can support more appropriate treatment and careful antibiotic use.

This year’s One Health theme highlights the value Anouk places on collaboration across research disciplines, connecting human health, animals and food. Having contributed to several European studies, Anouk hopes to continue working with colleagues towards a healthier future.

👤 James Deke | Giving newborns a better chance

When explaining the work to family, James asks them to imagine a newborn with a serious infection. Doctors must act quickly, sometimes before laboratory results are available. But what if the bacteria resist the antibiotics they would usually use?

James describes a part of his work as “building a better map”, testing bacteria from newborns with suspected sepsis in 13 hospitals across nine countries to understand which antibiotics inhibit them and how resistance varies. Alongside reviewing global research, James’s upcoming work in Ghana will compare bacteria from newborns with samples from wastewater and frequently touched surfaces, looking for links that could inform prevention.

James wishes more people understood that resistance develops in microbes. Anyone can acquire a resistant infection, even if they rarely take antibiotics themselves. This is why James sees responsible antibiotic use as one part of a wider effort that also includes rapid diagnostics, reliable laboratory testing, infection prevention and surveillance across human, animal and environmental health.

👤 Liesbet Van Heirstraeten | Protecting the smallest patients

For Liesbet, contributing to the fight against AMR starts with detecting resistance genes using molecular techniques such as real-time PCR. Through NeoIPC, this daily laboratory work helps reveal how widely resistant bacteria colonise newborns in European neonatal intensive care units.

One question gives this work a particularly human connection. Could optimised kangaroo care, involving skin-to-skin contact between caregivers and babies, also help reduce newborns’ acquisition of resistant bacteria?

Liesbet also examines the neonatal care environment, from scales and computer mice to incubator handles, to explore potential transmission routes. Together, these investigations aim to help protect newborns from bacteria that can cause severe infections and sepsis.